NPPB and chronic kidney disease: Thus, the aim of this study is to assess whether the interaction between NT-proBNP and fluid status is associated with adverse clinical outcomes, including commencing dialysis, MACEs and all-cause mortality in patients with CKD stages 4–5 not on dialysis.